Alnylam Pharmaceuticals: Building Value from the IP Estate (B) Harvard Case Solution & Analysis

Alnylam Pharmaceuticals: Building Value from the IP Estate (B) Case Solution

This is just an excerpt. This case is about  TECHNOLOGY & OPERATIONS

PUBLICATION DATE: November 14, 2016

The innovator of a pioneering biotech business in the siRNA area weighs his choices for scaling manufacturing capability in advance of an expected business launch. Functional intricacy and relative benefits of internal production versus a specialist design are talked about.

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.